Enhanced immuno-detection of shed extracellular domain of HER-2/neu
Date
2009-12-31
Journal Title
Journal ISSN
Volume Title
Publisher
Health
Abstract
HER-2/neu oncogene is over-expressed and amplified in patients associated with metastatic breast cancer. An increased level (>15 ng/mL) in the shed extracellular domain (sECD-HER 2/neu) is indicative of the potential presence and as-sociated progression of this disease. A fluo-rescent ELISA incorporating the newly devel-oped ALYGNSA antibody-orientation system revealed a 10-fold increase in sensitivity (?0.63 ng/mL) of sECD-HER 2/neu when compared to a control standard ELISA kit (?7.5 ng/mL). This enhanced mode of detection has the potential to not only address breast and other cancers per se but also permit an in depth evaluation of “shed extracellular domains”, in general, and the role of these “proteolytic derived factors” in physiological signalling at normal levels.
Description
Leslie R. Farris and Melisenda J. McDonald serve on the faculty at UMass Lowell in the Department of Chemistry.
item.page.type
Article
item.page.format
Keywords
Citation
Chourb, S., Mackness, B. C., Farris, L. R., McDonald, M. J. (2009, December 31). Enhanced immuno-detection of shed extracellular domain of HER-2/neu. Health 1(4), 325-329. http://www.scirp.org/journal/PaperInformation.aspx?paperID=1126&JournalID=65#.UuJwHBAo5D9